{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:31:37Z","timestamp":1780630297027,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T00:00:00Z","timestamp":1498780800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Anesth\/J Can Anesth"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s12630-017-0918-9","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T15:35:20Z","timestamp":1498836920000},"page":"940-946","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Serotonergic medications, herbal supplements, and perioperative serotonin syndrome","M\u00e9dicaments s\u00e9rotoninergiques, suppl\u00e9ments \u00e0 base de plantes m\u00e9dicinales et syndrome s\u00e9rotoninergique p\u00e9riop\u00e9ratoire"],"prefix":"10.1007","volume":"64","author":[{"given":"Mary E.","family":"Warner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Naranjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby N.","family":"Weingarten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juraj","family":"Sprung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,30]]},"reference":[{"key":"918_CR1","first-page":"533","volume":"13","author":"J Volpi-Abadie","year":"2013","unstructured":"Volpi-Abadie J, Kaye AM, Kaye AD. Serotonin syndrome. Ochsner J 2013; 13: 533-40.","journal-title":"Ochsner J"},{"key":"918_CR2","first-page":"215","volume":"81","author":"E Shopes","year":"2013","unstructured":"Shopes E, Gerard W, Baughman J. Methylene blue encephalopathy: a case report and review of published cases. AANA J 2013; 81: 215-21.","journal-title":"AANA J"},{"key":"918_CR3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","volume":"96","author":"EJ Dunkley","year":"2003","unstructured":"Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003; 96: 635-42.","journal-title":"QJM"},{"key":"918_CR4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.5694\/j.1326-5377.2007.tb01282.x","volume":"187","author":"GK Isbister","year":"2007","unstructured":"Isbister GK, Buckley NA, Whyte IM. Serotonin toxicity: a practical approach to diagnosis and treatment. Med J Aust 2007; 187: 361-5.","journal-title":"Med J Aust"},{"key":"918_CR5","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","volume":"314","author":"ED Kantor","year":"2015","unstructured":"Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in prescription drug use among adults in the United States from 1999-2012. JAMA 2015; 314: 1818-31.","journal-title":"JAMA"},{"key":"918_CR6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0976-9668.107253","volume":"4","author":"M Nagpal","year":"2013","unstructured":"Nagpal M, Sood S. Role of curcumin in systemic and oral health: an overview. J Nat Sci Biol Med 2013; 4: 3-7.","journal-title":"J Nat Sci Biol Med"},{"key":"918_CR7","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1208\/s12248-009-9146-8","volume":"11","author":"F Borrelli","year":"2009","unstructured":"Borrelli F, Izzo AA. Herb-drug interactions with St John\u2019s wort (Hypericum perforatum): an update on clinical observations. AAPS J 2009; 11: 710-27.","journal-title":"AAPS J"},{"key":"918_CR8","doi-asserted-by":"crossref","first-page":"2236S","DOI":"10.3945\/jn.111.157065","volume":"142","author":"JD Fernstrom","year":"2012","unstructured":"Fernstrom JD. Effects and side effects associated with the non-nutritional use of tryptophan by humans. J Nutr 2012; 142: 2236S-44S.","journal-title":"J Nutr"},{"key":"918_CR9","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1177\/0269881112458732","volume":"26","author":"AL Lopresti","year":"2012","unstructured":"Lopresti AL, Hood SD, Drummond PD. Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects. J Psychopharmacol 2012; 26: 1512-24.","journal-title":"J Psychopharmacol"},{"key":"918_CR10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/0250-474X.65012","volume":"72","author":"SK Kulkarni","year":"2010","unstructured":"Kulkarni SK, Dhir A. An overview of curcumin in neurological disorders. Indian J Pharm Sci 2010; 72: 149-54.","journal-title":"Indian J Pharm Sci"},{"key":"918_CR11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2007.08.045","volume":"578","author":"R Wang","year":"2008","unstructured":"Wang R, Xu Y, Wu HL, et al. The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors. Eur J Pharmacol 2008; 578: 43-50.","journal-title":"Eur J Pharmacol"},{"key":"918_CR12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.brainres.2008.01.104","volume":"1210","author":"R Wang","year":"2008","unstructured":"Wang R, Li YB, Li YH, Xu Y, Wu HL, Li XJ. Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB. Brain Res 2008; 1210: 84-91.","journal-title":"Brain Res"},{"key":"918_CR13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00213-008-1300-y","volume":"201","author":"SK Kulkarni","year":"2008","unstructured":"Kulkarni SK, Bhutani MK, Bishnoi M. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology (Berl) 2008; 201: 435-42.","journal-title":"Psychopharmacology (Berl)"},{"key":"918_CR14","first-page":"871","volume":"49","author":"FJ Mackay","year":"1999","unstructured":"Mackay FJ, Dunn NR, Mann RD. Antidepressants and the serotonin syndrome in general practice. Br J Gen Pract 1999; 49: 871-4.","journal-title":"Br J Gen Pract"},{"key":"918_CR15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jemermed.2008.01.003","volume":"38","author":"R Kirschner","year":"2010","unstructured":"Kirschner R, Donovan JW. Serotonin syndrome precipitated by fentanyl during procedural sedation. J Emerg Med 2010; 38: 477-80.","journal-title":"J Emerg Med"},{"key":"918_CR16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/bja\/aei210","volume":"95","author":"PK Gillman","year":"2005","unstructured":"Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth 2005; 95: 434-41.","journal-title":"Br J Anaesth"},{"key":"918_CR17","first-page":"340","volume":"82","author":"E Greenier","year":"2014","unstructured":"Greenier E, Lukyanova V, Reede L. Serotonin syndrome: fentanyl and selective serotonin reuptake inhibitor interactions. AANA J 2014; 82: 340-5.","journal-title":"AANA J"},{"key":"918_CR18","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/ALN.0b013e31823940c0","volume":"115","author":"R Rastogi","year":"2011","unstructured":"Rastogi R, Swarm RA, Patel TA. Case scenario: opioid association with serotonin syndrome: implications to the practitioners. Anesthesiology 2011; 115: 1291-8.","journal-title":"Anesthesiology"},{"key":"918_CR19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jclinane.2014.11.002","volume":"27","author":"KJ Larson","year":"2015","unstructured":"Larson KJ, Wittwer ED, Nicholson WT, Weingarten TN, Price DL, Sprung J. Myoclonus in patient on fluoxetine after receiving fentanyl and low-dose methylene blue during sentinel lymph node biopsy. J Clin Anesth 2015; 27: 247-51.","journal-title":"J Clin Anesth"},{"key":"918_CR20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00540-014-1973-9","volume":"29","author":"T Kawano","year":"2015","unstructured":"Kawano T, Takahashi T, Kaminaga S, et al. A comparison of midazolam and dexmedetomidine for the recovery of serotonin syndrome in rats. J Anesth 2015; 29: 631-4.","journal-title":"J Anesth"},{"key":"918_CR21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11011-008-9095-4","volume":"23","author":"AC Muller","year":"2008","unstructured":"Muller AC, Daya S. Acyclovir inhibits rat liver tryptophan-2,3-dioxygenase and induces a concomitant rise in brain serotonin and 5\u2013hydroxyindole acetic acid levels. Metab Brain Dis 2008; 23: 351-60.","journal-title":"Metab Brain Dis"},{"key":"918_CR22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/FTD.0000000000000101","volume":"37","author":"C Gjestad","year":"2015","unstructured":"Gjestad C, Westin AA, Skogvoll E, Spigset O. Effect of proton pump inhibitors on the serum concentrations of the selective serotonin reuptake inhibitors citalopram, escitalopram, and sertraline. Ther Drug Monit 2015; 37: 90-7.","journal-title":"Ther Drug Monit"},{"key":"918_CR23","unstructured":"U.S. Food and Drug Administration. FDA drug safety communication: serious CNS reactions possible when methylene blue is given to patients taking certain psychiatric medications - 20011. Available from URL: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm263190.htm (accessed April 2017)."},{"key":"918_CR24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4088\/PCC.v02n0602","volume":"2","author":"PA Marken","year":"2000","unstructured":"Marken PA, Munro JS. Selecting a selective serotonin reuptake inhibitor: clinically important distinguishing features. Prim Care Companion J Clin Psychiatry 2000; 2: 205-10.","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"918_CR25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0735-6757(03)00088-3","volume":"21","author":"WA Watson","year":"2003","unstructured":"Watson WA, Litovitz TL, Rodgers GC Jr, et al. 2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2003; 21: 353-421.","journal-title":"Am J Emerg Med"},{"key":"918_CR26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0028-3908(82)90149-6","volume":"21","author":"LL Martin","year":"1982","unstructured":"Martin LL, Bouchal RL, Smith DJ. Ketamine inhibits serotonin uptake in vivo. Neuropharmacology 1982; 21: 113-8.","journal-title":"Neuropharmacology"},{"key":"918_CR27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-013-3024-x","volume":"228","author":"V Gigliucci","year":"2013","unstructured":"Gigliucci V, O\u2019Dowd G, Casey S, Egan D, Gibney S, Harkin A. Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism. Psychopharmacology (Berl) 2013; 228: 157-66.","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Canadian Journal of Anesthesia\/Journal canadien d'anesth\u00e9sie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12630-017-0918-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-017-0918-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-017-0918-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T09:17:34Z","timestamp":1602407854000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12630-017-0918-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,30]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["918"],"URL":"https:\/\/doi.org\/10.1007\/s12630-017-0918-9","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,30]]}}}